Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Harvard Business School
Deloitte
Federal Trade Commission
US Army
Mallinckrodt
Merck
Medtronic

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076019

« Back to Dashboard

NDA 076019 describes DEFEROXAMINE MESYLATE, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson Labs, and West-ward Pharms Int, and is included in five NDAs. It is available from five suppliers. Additional details are available on the DEFEROXAMINE MESYLATE profile page.

The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Summary for 076019
Tradename:DEFEROXAMINE MESYLATE
Applicant:Hospira
Ingredient:deferoxamine mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076019
Mechanism of ActionIron Chelating Activity
Medical Subject Heading (MeSH) Categories for 076019
Suppliers and Packaging for NDA: 076019
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 076019 ANDA Hospira, Inc. 0409-2336 N 0409-2336-13
DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 076019 ANDA Hospira, Inc. 0409-2336 N 0409-2336-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Mar 17, 2004TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:Mar 17, 2004TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
QuintilesIMS
UBS
Federal Trade Commission
Harvard Business School
AstraZeneca
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.